In the UK, the first hearing in the FSA’s high-profile insider trading case against two lawyers from US-based law firms accused of insider trading took place this morning. As previously discussed here, Former Dorsey & Whitney corporate partner Andrew Rimmington, former McDermott Will & Emery partner Michael McFall, and the former financial director of Neutec Pharma, Peter King have been charged by the FSA in connection with insider dealing relating to Novartis’ 2006 takeover of Neutec.
Legal Week reports that today, all three men “were granted unconditional bail at Horsferry Road Magistrates Court with 10 July pencilled in as the date of the next hearing for one of the defendants, with a committal hearing scheduled for 28 July.”
[…] the FSA launches its insider trading case in the UK against former Dorsey & Whitney corporate partner Andrew Rimmington, Dorsey & […]